Literature DB >> 26702804

Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States.

Melissa J Danesh1, Alexa B Kimball2.   

Abstract

Entities:  

Keywords:  anti-IL-17RA; brodalumab; depression; economic recession; monoclonal antibody; suicidal ideation; suicide

Mesh：

Substances：

Year:  2016        PMID： 26702804     DOI： 10.1016/j.jaad.2015.08.057

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

2.  Dermatologic Conditions and Risk of Suicide: A Case-Control Study.

Authors:  Deepak Prabhakar; Edward L Peterson; Yong Hu; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; L Keoki Williams; Arne Beck; Gregory E Simon; Brian K Ahmedani
Journal:  Psychosomatics       Date:  2017-08-04       Impact factor: 2.386

3.  Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Authors:  Marina Talamonti; Giovanna Malara; Ylenia Natalini; Federico Bardazzi; Andrea Conti; Andrea Chiricozzi; Cristina Mugheddu; Paolo Gisondi; Stefano Piaserico; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Franca Cantoresi; Maria Concetta Fargnoli; Anna Balato; Francesco Loconsole; Annamaria Offidani; Claudio Bonifati; Francesca Prignano; Marta Bartezaghi; Alice Rausa; Elisabetta Aloisi; Roberto Orsenigo; Antonio Costanzo
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

Review 4.  Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.

Authors:  Manish K Jha; Madhukar H Trivedi
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

Review 5.  Mechanistic rationales for targeting interleukin-17A in spondyloarthritis.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Arthritis Res Ther       Date:  2017-03-08       Impact factor: 5.156

Review 6.  Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice.

Authors:  Pierre Miossec
Journal:  RMD Open       Date:  2017-02-15

7.  Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data.

Authors:  Imke Redeker; Falk Hoffmann; Johanna Callhoff; Hildrun Haibel; Joachim Sieper; Angela Zink; Denis Poddubnyy
Journal:  Ann Rheum Dis       Date:  2018-03-10       Impact factor: 19.103

Review 8.  Secukinumab for rheumatology: development and its potential place in therapy.

Authors:  Marije I Koenders; Wim B van den Berg
Journal:  Drug Des Devel Ther       Date:  2016-06-24       Impact factor: 4.162
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.